Company: CERO
Filing Date: 2025-08-11
Form Type: S-3
Source: 0001213900-25-073849
Chunk: 27

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-11
Form: S-3
Chunk 27
---
 the marketability
of the shares of common stock and the ability of any person or entity to engage in market-making activities with respect to the shares
of common stock.

We will pay all expenses of the registration of the shares of common
stock pursuant to the registration rights agreement, estimated to be $101,000 in total, including, without limitation, Securities and
Exchange Commission filing fees and expenses of compliance with state securities or “blue sky” laws; provided, however, a
selling stockholder will pay all underwriting discounts and selling commissions, if any. We will indemnify the Selling Stockholders against
liabilities, including some liabilities under the Securities Act in accordance with the registration rights agreements or the Selling
Stockholders will be entitled to contribution. We may be indemnified by the Selling Stockholders against civil liabilities, including
liabilities under the Securities Act that may arise from any written information furnished to us by the selling stockholder specifically
for use in this prospectus, in accordance with the related registration rights agreements or we may be entitled to contribution.

Once sold under the registration statement, of
which this prospectus forms a part, the shares of common stock will be freely tradable in the hands of persons other than our affiliates.

<div align='center'>12

LEGAL MATTERS</div>

Goodwin Procter LLP has passed
upon the validity of the shares of our Common Stock offered by this prospectus and certain other legal matters related to this prospectus.

<div align='center'>EXPERTS</div>

The consolidated financial statements of CERo Therapeutics Holdings,
Inc. as of December 31, 2024 and 2023, and for each of the two years in the period ended December 31, 2024, incorporated by reference
in this prospectus have been audited by Wolf & Company, P.C., an independent registered public accounting firm, as stated in their
report. Such financial statements are incorporated by reference in reliance upon such report given on the authority of such firm as experts
in accounting and auditing.

<div align='center'>WHERE YOU CAN FIND MORE INFORMATION</div>

We have filed a registration
statement on Form S-3, including exhibits, under the Securities Act with respect to the shares of our Common Stock offered by this prospectus.
This prospectus constitutes only a part of the registration statement. Some items are contained in exhibits to the registration statement
as permitted by the rules and regulations of the SEC. For further information with respect to us and our securities,